Twist Bioscience Corporation (TWST)

NASDAQ

$31.05

+$0.12 (0.39%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$30.47$31.78

Open $31.78

52 Week Range

$23.30$55.33

Previous Close $30.93

Market Cap1.86B

Volume669.05K

Avg Volume1.74M

P/E (TTM)-24.21

EPS (TTM)$-1.28

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Twist Bioscience Corporation

DEC122025

Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights

Source: Business Wire•3 days ago

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. If you currently own Twi...

DEC42025

Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research

Source: Business Wire•12 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech c...

DEC32025

Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm

Source: GlobeNewsWire•13 days ago

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders....

NOV142025

Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Source: Business Wire•32 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended Se...

NOV32025

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Source: Business Wire•43 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that it has granted...

OCT242025

Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights

Source: Business Wire•53 days ago

OCT162025

Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm

Source: PRNewsWire•60 days ago

NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders. Acc...

OCT62025

Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System

Source: Business Wire•71 days ago

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today...

OCT22025

Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

Source: Business Wire•74 days ago

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced the publication in Science of the peer-reviewed paper, “Strengthening nucleic acid biosecurity scre...